In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 22, No. 41 ( 2017-10-12)
Abstract:
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate.
Type of Medium:
Online Resource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2017.22.41.17-00645
Language:
English
Publisher:
European Centre for Disease Control and Prevention (ECDC)
Publication Date:
2017
detail.hit.zdb_id:
2059112-3